JP2021512087A5 - - Google Patents
Info
- Publication number
- JP2021512087A5 JP2021512087A5 JP2020541535A JP2020541535A JP2021512087A5 JP 2021512087 A5 JP2021512087 A5 JP 2021512087A5 JP 2020541535 A JP2020541535 A JP 2020541535A JP 2020541535 A JP2020541535 A JP 2020541535A JP 2021512087 A5 JP2021512087 A5 JP 2021512087A5
- Authority
- JP
- Japan
- Prior art keywords
- egfr
- alkyl
- independently
- halogen
- monosubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023180451A JP7738619B2 (ja) | 2018-01-31 | 2023-10-19 | Erbb/btk阻害剤 |
| JP2025145276A JP2025179139A (ja) | 2018-01-31 | 2025-09-02 | Erbb/btk阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/074791 | 2018-01-31 | ||
| CN2018074791 | 2018-01-31 | ||
| CNPCT/CN2018/118569 | 2018-11-30 | ||
| CN2018118569 | 2018-11-30 | ||
| PCT/CN2019/073355 WO2019149164A1 (en) | 2018-01-31 | 2019-01-28 | Erbb/btk inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023180451A Division JP7738619B2 (ja) | 2018-01-31 | 2023-10-19 | Erbb/btk阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512087A JP2021512087A (ja) | 2021-05-13 |
| JP2021512087A5 true JP2021512087A5 (cg-RX-API-DMAC7.html) | 2022-02-02 |
| JP7427597B2 JP7427597B2 (ja) | 2024-02-05 |
Family
ID=67478612
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541535A Active JP7427597B2 (ja) | 2018-01-31 | 2019-01-28 | Erbb/btk阻害剤 |
| JP2023180451A Active JP7738619B2 (ja) | 2018-01-31 | 2023-10-19 | Erbb/btk阻害剤 |
| JP2025145276A Pending JP2025179139A (ja) | 2018-01-31 | 2025-09-02 | Erbb/btk阻害剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023180451A Active JP7738619B2 (ja) | 2018-01-31 | 2023-10-19 | Erbb/btk阻害剤 |
| JP2025145276A Pending JP2025179139A (ja) | 2018-01-31 | 2025-09-02 | Erbb/btk阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11007198B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4356975A3 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7427597B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20250046340A (cg-RX-API-DMAC7.html) |
| CN (4) | CN111909131B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019215538B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3086616A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3746424T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2977484T3 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2020007947A (cg-RX-API-DMAC7.html) |
| PT (1) | PT3746424T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2764069C1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI798334B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019149164A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI798334B (zh) * | 2018-01-31 | 2023-04-11 | 大陸商迪哲(江蘇)醫藥股份有限公司 | Erbb/btk抑制劑 |
| US11896597B2 (en) * | 2018-01-31 | 2024-02-13 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | ErbB/BTK inhibitors |
| US12157730B2 (en) | 2019-03-19 | 2024-12-03 | Voronoi Inc. | Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component |
| JP7109013B2 (ja) | 2019-03-19 | 2022-07-29 | ボロノイ インコーポレイテッド | ヘテロアリール誘導体、ヘテロアリール誘導体の生成方法、およびヘテロアリール誘導体を有効成分として含む医薬組成物 |
| WO2021104305A1 (zh) * | 2019-11-26 | 2021-06-03 | 上海翰森生物医药科技有限公司 | 含氮多环类衍生物抑制剂、其制备方法和应用 |
| CN111057021B (zh) * | 2019-12-11 | 2023-05-23 | 中国药科大学 | 均三嗪类化合物及其制备方法和用途 |
| AU2021205834A1 (en) * | 2020-01-07 | 2022-08-25 | Dana-Farber Cancer Institute, Inc. | Cyano-pyrimidine inhibitors of EGFR/HER2 |
| CN111470998B (zh) * | 2020-06-28 | 2020-09-25 | 上海皓元生物医药科技有限公司 | 用于合成喜树碱衍生物的中间体及其制备方法和用途 |
| CN112409281B (zh) * | 2020-08-20 | 2022-11-18 | 上海大学 | (e)-3-(3-氯-2-氟-6-(1h-四氮唑-1-基)苯基)丙烯酸的合成方法 |
| CN112679446A (zh) * | 2020-10-26 | 2021-04-20 | 都创(上海)医药科技有限公司 | 一种合成反式-3-(3-氯-2-氟-6-(1h-四氮唑-1-基)苯基)丙烯酸的方法 |
| CN116670127A (zh) * | 2021-03-30 | 2023-08-29 | 贝达药业股份有限公司 | Egfr抑制剂及其组合物和用途 |
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| BR112023025660A2 (pt) * | 2021-07-02 | 2024-02-27 | Aldeyra Therapeutics Inc | Compostos de captação de aldeído heterocíclicos e usos dos mesmos |
| AU2022324410A1 (en) * | 2021-08-02 | 2024-01-18 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel pharmaceutical salts and polymorphic forms of an erbb and btk inhibitor |
| CN115181093B (zh) * | 2022-08-01 | 2023-04-25 | 重庆医科大学 | Sunvozertinib中间体的制备方法 |
| EP4731307A1 (en) | 2023-06-23 | 2026-04-29 | Assia Chemical Industries Ltd. | Solid state forms of sunvozertinib |
| WO2025247783A1 (en) | 2024-05-29 | 2025-12-04 | Syngenta Crop Protection Ag | Pesticidally active dihydro-benzoxazinone compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100799534B1 (ko) * | 2004-02-27 | 2008-01-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신규 피리딘 유도체 및 피리미딘 유도체(1) |
| AU2009262068C1 (en) * | 2008-06-27 | 2015-07-02 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
| US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| HUE033177T2 (en) * | 2012-01-17 | 2017-11-28 | Astellas Pharma Inc | Pyrazine carboxamide compound |
| JP6317320B2 (ja) * | 2012-03-15 | 2018-04-25 | セルジーン シーエーアール エルエルシー | 上皮成長因子受容体キナーゼ阻害剤の塩 |
| JP6469567B2 (ja) * | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
| CN104854101B (zh) | 2012-11-06 | 2018-05-01 | 上海复尚慧创医药研究有限公司 | Alk激酶抑制剂 |
| JP6510510B2 (ja) * | 2013-07-11 | 2019-05-08 | ベータ ファーマシューティカルズ カンパニー リミテッド | プロテインチロシンキナーゼモジュレーター及び使用方法 |
| CA2920534A1 (en) | 2013-08-12 | 2015-02-19 | Pharmacyclics Llc | Methods for the treatment of her2 amplified cancer |
| CN105384694B (zh) * | 2014-08-22 | 2020-09-04 | 四川海思科制药有限公司 | 一种取代的氨基嘧啶衍生物及其制备方法和药物用途 |
| CN106883213B (zh) * | 2015-12-15 | 2021-04-20 | 合肥中科普瑞昇生物医药科技有限公司 | 一种egfr和alk激酶的双重抑制剂 |
| CN106905245B (zh) * | 2015-12-23 | 2021-06-25 | 正大天晴药业集团股份有限公司 | 2,4-二取代的嘧啶类化合物 |
| CN106928150B (zh) * | 2015-12-31 | 2020-07-31 | 恩瑞生物医药科技(上海)有限公司 | 丙烯酰胺苯胺衍生物及其药学上的应用 |
| CN106083736A (zh) * | 2016-06-21 | 2016-11-09 | 郑州泰基鸿诺医药股份有限公司 | 一种嘧啶类化合物、egfr抑制剂及其应用 |
| TWI798334B (zh) * | 2018-01-31 | 2023-04-11 | 大陸商迪哲(江蘇)醫藥股份有限公司 | Erbb/btk抑制劑 |
| KR102782739B1 (ko) * | 2018-03-13 | 2025-03-20 | 보로노이 주식회사 | 2,4,5-치환된 피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 |
-
2019
- 2019-01-17 TW TW108101860A patent/TWI798334B/zh active
- 2019-01-28 CN CN202010660882.XA patent/CN111909131B/zh active Active
- 2019-01-28 PT PT197482599T patent/PT3746424T/pt unknown
- 2019-01-28 KR KR1020257009058A patent/KR20250046340A/ko active Pending
- 2019-01-28 ES ES19748259T patent/ES2977484T3/es active Active
- 2019-01-28 RU RU2020127393A patent/RU2764069C1/ru active
- 2019-01-28 CA CA3086616A patent/CA3086616A1/en active Pending
- 2019-01-28 WO PCT/CN2019/073355 patent/WO2019149164A1/en not_active Ceased
- 2019-01-28 MX MX2020007947A patent/MX2020007947A/es unknown
- 2019-01-28 EP EP24161138.3A patent/EP4356975A3/en active Pending
- 2019-01-28 EP EP19748259.9A patent/EP3746424B1/en active Active
- 2019-01-28 CN CN202610219448.5A patent/CN122464860A/zh active Pending
- 2019-01-28 KR KR1020207025029A patent/KR102786279B1/ko active Active
- 2019-01-28 CN CN202010659802.9A patent/CN111747934A/zh active Pending
- 2019-01-28 DK DK19748259.9T patent/DK3746424T3/da active
- 2019-01-28 JP JP2020541535A patent/JP7427597B2/ja active Active
- 2019-01-28 CN CN201980006427.3A patent/CN111587244A/zh active Pending
- 2019-01-28 AU AU2019215538A patent/AU2019215538B2/en active Active
-
2020
- 2020-06-24 US US16/910,208 patent/US11007198B2/en active Active
- 2020-07-28 MX MX2023010411A patent/MX2023010411A/es unknown
-
2021
- 2021-04-07 US US17/224,121 patent/US11504375B2/en active Active
-
2023
- 2023-04-06 AU AU2023202151A patent/AU2023202151B2/en active Active
- 2023-10-19 JP JP2023180451A patent/JP7738619B2/ja active Active
-
2025
- 2025-09-02 JP JP2025145276A patent/JP2025179139A/ja active Pending